Artiva Biotherapeutics (ARTV) Cash from Operations (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Cash from Operations of 20950000.0 for Q1 2026, down 5.59% year-over-year from 22190313.37 in Q1 2025, and down 41.79% quarter-over-quarter from 14775000.0 in Q4 2025.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Cash from Operations (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Cash from Operations for 4 consecutive years, with 20950000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 5.59% year-over-year to 20950000.0; the TTM figure through Mar 2026 stood at 77909000.0 (down 30.31% YoY), while the FY2025 annual figure was 76800000.0, down 39.56% from the prior year.
- Cash from Operations fell to 20950000.0 in Q1 2026 per ARTV's latest filing, from 14775000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 10675000.0 in Q4 2023 and bottomed at 22983000.0 in Q2 2025.
- Historically, Cash from Operations has averaged 15836818.18 across 4 years, with a median of 14775000.0 in 2025.
- On a YoY basis, Cash from Operations climbed as much as 0.85% in 2025 and fell as far as 67.94% in 2025.
- Artiva Biotherapeutics' Cash from Operations stood at 10675000.0 in 2023, then plunged by 37.24% to 14650000.0 in 2024, then slipped by 0.85% to 14775000.0 in 2025, then tumbled by 41.79% to 20950000.0 in 2026.
- Business Quant data shows ARTV's Cash from Operations at 20950000.0 in Q1 2026, 14775000.0 in Q4 2025, and 19201000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Artiva Biotherapeutics | 441.23 Mn | 441.23 Mn | - | -20.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.31 Mn |
| Mar 31, 2026 | -21.00 Mn |
| Dec 31, 2025 | -14.78 Mn |
| Sep 30, 2025 | -19.20 Mn |
| Jun 30, 2025 | -22.98 Mn |
| Mar 31, 2025 | -19.84 Mn |
| Dec 31, 2024 | -14.65 Mn |
| Sep 30, 2024 | -11.61 Mn |
| Jun 30, 2024 | -13.69 Mn |
| Mar 31, 2024 | -15.09 Mn |
| Dec 31, 2023 | -10.68 Mn |
| Sep 30, 2023 | -10.75 Mn |